SBIR/STTR Research Award
Real-Time Small-Volume Blood Sampling and Analysis for Coagulopathy of Trauma Analytes
Award amount
$3,049,750Program and phase
SBIR · Phase IIAward year
2020Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- APTITUDE MEDICAL SYSTEMS INC
- Proposal award date
- 2020-07-06
- Contract end date
- 2021-11-05
- UEI
- NWWEFYLD9JC3
- Solicitation number
- 15.1
- Topic code
- DHP15-012
Research abstract
Traumatic hemorrhage is the primary mechanism of death in potentially survivable combat injuries, and is the leading cause of death for civilians under the age of 44. A major underlying cause of this high mortality is Acute Traumatic Coagulopathy, a deadl
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Developing multi-specific aptamers for safe, potent, and long-lasting treatment of geographic atrophy
- Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
- Developing a multivalent agent for long-lasting treatment of diabetic macular edema
- Targeting SDF-1 for effective wet AMD treatment
- Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Microfluidic Real-Time Monitoring Array with Graphene Enhanced Impedance Sensing for Coagulation Biomarker Profiling
- Inexpensive, Small, Biocompatible, Multi-Analyte, Voltammetric Blood Sensors Based on Functionalized Microporous Membranes, with, Impervious
- Universal Microfluidic Device Platform to Enable Real-Time Continuous Measurement of Biomarkers of Coagulopathy Directly in Trauma Victims
- Microfluidic Real-Time Monitoring Array with Graphene Enhanced Impedance Sensing for Coagulation Biomarker Profiling
Research funding history
24 SBIR/STTR records share this UEI (2014–2022). Reported award amounts total $15,162,025. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense